Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Inventory Average (2016 - 2025)

Ani Pharmaceuticals' Inventory Average history spans 13 years, with the latest figure at $144.8 million for Q4 2025.

  • For Q4 2025, Inventory Average rose 1.66% year-over-year to $144.8 million; the TTM value through Dec 2025 reached $144.8 million, up 1.66%, while the annual FY2025 figure was $139.9 million, 12.85% up from the prior year.
  • Inventory Average for Q4 2025 was $144.8 million at Ani Pharmaceuticals, up from $142.4 million in the prior quarter.
  • Across five years, Inventory Average topped out at $144.8 million in Q4 2025 and bottomed at $65.7 million in Q1 2021.
  • The 5-year median for Inventory Average is $105.0 million (2023), against an average of $107.2 million.
  • The largest annual shift saw Inventory Average soared 45.62% in 2022 before it rose 1.66% in 2025.
  • A 5-year view of Inventory Average shows it stood at $71.7 million in 2021, then surged by 40.36% to $100.6 million in 2022, then grew by 8.22% to $108.9 million in 2023, then skyrocketed by 30.78% to $142.4 million in 2024, then rose by 1.66% to $144.8 million in 2025.
  • Per Business Quant, the three most recent readings for ANIP's Inventory Average are $144.8 million (Q4 2025), $142.4 million (Q3 2025), and $137.9 million (Q2 2025).